Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT05643118 · COMPLETED
Trial details
- NCT number
- NCT05643118
- Sponsor
- Olix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2024-11-25
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.